Metraipolis › archive › dc_f0680973aa89

Emerging Therapeutics in COPD: Mapping Innovation to Treatable Traits — Europe PMC PMID:40900345

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40900345
DOI
10.1007/s00408-[numero omesso]-0
License (as archived)
solo-consultazione
Archived
2026-11-10T03:51:11.718Z
SHA-256 of the archived text
69fdb06499292ac475c8cdceb9f172b2947e8a369ae0dd9482cf836a00aff84c
Stable URL of this page
https://metraipolis.com/documento/dc_f0680973aa89

How to cite

Emerging Therapeutics in COPD: Mapping Innovation to Treatable Traits — Europe PMC PMID:40900345 — Europe PMC (en), https://europepmc.org/article/MED/40900345 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f0680973aa89 (Metraipolis archive dc_f0680973aa89, sha256 69fdb06499292ac475c8cdceb9f172b2947e8a369ae0dd9482cf836a00aff84c)
BibTeX
@misc{dcf0680973aa89,
  title = {Emerging Therapeutics in COPD: Mapping Innovation to Treatable Traits — Europe PMC PMID:40900345},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40900345},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f0680973aa89; sha256 69fdb06499292ac475c8cdceb9f172b2947e8a369ae0dd9482cf836a00aff84c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40900345. Agents can read the archived copy with the MCP tool read_document.